Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263897 · ClinicalTrials.gov registry record · NA
Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief
A NA study, sponsored by Caps Research Network.
- Terminated
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT03263897 is a NA study that was terminated before completion, run by Caps Research Network. The registered enrollment target is 59 participants.
The verdict
NCT03263897, a NA study, was terminated before completion, sponsored by Caps Research Network.
- TERMINATED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
Evaluate the feasibility of using a mobile interface to control the insufflator device administering treatment for aborting (stopping) an acute episode of migraine. The patient, under clinical supervision, will use the mobile interface to "self administer" the treatment when experiencing an acute episode of migraine. The supervising clinician will monitor the patient and the device to make sure that no harm could come to the patient and will be ready to intervene if any adverse effects were suspected to or in the process of happening.
Interventions
- DEVICE insufflation
- DEVICE placebo insufflation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03263897
The ClinicalTrials.gov registry entry for NCT03263897 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Caps Research Network, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which insufflation is the first listed.
NCT03263897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03263897 about?
NCT03263897 is a clinical study titled "Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief". Evaluate the feasibility of using a mobile interface to control the insufflator device administering treatment for aborting (stopping) an acute episode of migraine. The patient, under clinical supervision, will use the mobile interface to "self administer" the treatment when experiencing an acute ep...
What is the current status of trial NCT03263897?
This trial is currently terminated. It is a NA study. The enrollment target is 59 participants. The study started on 2017-08-21. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03263897?
The interventions under investigation include: insufflation (DEVICE), placebo insufflation (DEVICE).
Who is sponsoring clinical trial NCT03263897?
This trial is sponsored by Caps Research Network, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.